-
公开(公告)号:US20220143168A1
公开(公告)日:2022-05-12
申请号:US17433945
申请日:2020-02-27
申请人: Evaxion Biotech A/S
IPC分类号: A61K39/102 , C07K14/285 , A61K39/39
摘要: Immunogenic proteins from nontypable Haemophilus influenzae as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Methods for prophylaxis of infection with nontypable Haemophilus influenzae using the proteins, nucleic acids, vectors or transformed cells.
-
公开(公告)号:US20220073570A1
公开(公告)日:2022-03-10
申请号:US17532034
申请日:2021-11-22
申请人: Evaxion Biotech A/S
IPC分类号: C07K14/21 , A61K39/104 , A61K47/64 , A61P31/04 , C07K16/12
摘要: Disclosed are immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cells.
-
公开(公告)号:US20230045507A1
公开(公告)日:2023-02-09
申请号:US17816145
申请日:2022-07-29
申请人: Evaxion Biotech A/S
IPC分类号: C07K14/31 , A61K39/085 , A61P31/04
摘要: Disclosed is chimeric polypeptides derived from S. aureus proteins having SEQ ID NOs: 1-9 and 139-146. The chimeric polypeptides are useful as immunogens for providing protective immunity against S. aureus infection. Also disclosed are compositions, methods of treatment and prophylaxis, nucleic acids and vectors comprising the nucleic acids.
-
公开(公告)号:US20240317817A1
公开(公告)日:2024-09-26
申请号:US18732821
申请日:2024-06-04
申请人: Evaxion Biotech A/S
CPC分类号: C07K14/21 , A61K39/104 , A61K47/6415 , A61K47/643 , A61K47/646 , A61P31/04 , C07K16/1214 , A61K2039/545 , A61K2039/55505 , A61K2039/575
摘要: Disclosed are immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformd cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cells.
-
公开(公告)号:US12006342B2
公开(公告)日:2024-06-11
申请号:US17532034
申请日:2021-11-22
申请人: Evaxion Biotech A/S
CPC分类号: C07K14/21 , A61K39/104 , A61K47/6415 , A61K47/643 , A61K47/646 , A61P31/04 , C07K16/1214 , A61K2039/545 , A61K2039/55505 , A61K2039/575
摘要: Disclosed are immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cells.
-
公开(公告)号:US20240076325A1
公开(公告)日:2024-03-07
申请号:US18340479
申请日:2023-06-23
申请人: Evaxion Biotech A/S
IPC分类号: C07K14/21 , A61K39/104 , A61P31/04 , C07K14/33 , C07K14/34 , C07K14/435 , C07K16/12 , C12Q1/689 , G01N33/569
CPC分类号: C07K14/21 , A61K39/104 , A61P31/04 , C07K14/33 , C07K14/34 , C07K14/43504 , C07K16/1214 , C12Q1/689 , G01N33/56911 , A61K2039/505
摘要: Immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cel
-
公开(公告)号:US11718648B2
公开(公告)日:2023-08-08
申请号:US16473443
申请日:2018-01-05
申请人: Evaxion Biotech A/S
IPC分类号: C07K14/21 , A61P31/04 , A61K39/104 , C07K14/33 , C07K14/34 , C07K14/435 , C07K16/12 , C12Q1/689 , G01N33/569 , A61K39/00
CPC分类号: C07K14/21 , A61K39/104 , A61P31/04 , C07K14/33 , C07K14/34 , C07K14/43504 , C07K16/1214 , C12Q1/689 , G01N33/56911 , A61K2039/505 , A61K2039/55505 , A61K2039/6037 , A61K2039/6081 , A61K2039/627
摘要: Disclosed are immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cells.
-
公开(公告)号:US20230050225A1
公开(公告)日:2023-02-16
申请号:US17791038
申请日:2021-01-06
申请人: Evaxion Biotech A/S
IPC分类号: A61K39/095 , A61P31/04
摘要: Proteins, protein fragments, nucleic acids and vectors derived from Neisseria gonorrhoeae, as well as to methods of inducing immunity against N. gonorrhoeae. Also disclosed are antibodies binding to the proteins and protein fragments.
-
公开(公告)号:US20210386847A1
公开(公告)日:2021-12-16
申请号:US17351032
申请日:2021-06-17
申请人: Evaxion Biotech A/S
IPC分类号: A61K39/085 , C07K16/12 , C12Q1/689 , C07K14/31
摘要: Disclosed are novel immunogenic proteins derived from Staphylococcus aureus, as well as methods for their use in conferring protective immunity against S. aureus infections. Also disclosed are nucleic acids encoding the proteins and methods of use of these nucleic acids.
-
-
-
-
-
-
-
-